Loading clinical trials...
Loading clinical trials...
A Randomized, Open-label, 2-period, Parallel Group, Multiple-dose Study to Evaluate the Drug-drugs Interaction Between Dorzolamide and Brimonidine in Healthy Korean Male Volunteers
Conditions
Interventions
[A]
[B]
+2 more
Locations
1
South Korea
Clinical Trial Center, Seoul National University Hospital
Seoul, South Korea
Start Date
December 1, 2016
Primary Completion Date
December 1, 2017
Completion Date
April 1, 2018
Last Updated
April 11, 2018
NCT07539675
NCT07322302
NCT06289491
NCT07496957
NCT04354545
NCT07455786
Lead Sponsor
Kukje Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions